Human Papillomavirus (HPV) 6, 11, 16, and 18 Seroprevalence Is Associated with Sexual Practice and Age: Results from the Multinational HPV Infection in Men Study (HIM Study)
- 1 May 2011
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 20 (5) , 990-1002
- https://doi.org/10.1158/1055-9965.epi-10-1160
Abstract
Background: Few human papillomavirus (HPV) serology studies have evaluated type-specific seroprevalence of vaccine HPV types in men. This study investigates seroprevalence of HPV 6, 11, 16, and 18, and associated risk factors in men residing in three countries (United States, Mexico, and Brazil). Methods: Data from 1,477 men aged 18 to 70 enrolled in the HPV Infection in Men Study (HIM Study) were analyzed. Serum antibody testing was performed with virus-like particle-based ELISA. Potential risk factors were assessed for individual HPV types by the use of logistic regression. Results: Overall, HPV-6, 11, 16, and 18 seroprevalence was 14.8%, 17.3%, 11.2%, and 5.8%, respectively. Thirty-four percent of men were seropositive to one or more HPV types. When examined by sexual practice, 31.2% of men who had sex with women, 65.6% of men who had sex with men (MSM), and 59.4% of men who had sex with both men and women (MSMW) were seropositive to one or more HPV types. Seroprevalence increased with age among young-to-middle-aged men with significant upward age trends observed for HPV 11, 16, and 18. Men with multiple lifetime male anal sex partners were 2 to 4 times more likely to be HPV 6 or 11 seropositive and 3 to 11 times more likely to be HPV 16 or 18 seropositive. Conclusion: Our data indicate that exposures to vaccine HPV types were common in men and highly prevalent among MSM and MSMW. Impact: Our study provides strong evidence that the practice of same-sex anal intercourse is an independent risk factor for seroprevalence of individual vaccine HPV types. Examination of antibody responses to HPV infections at various anatomic sites in future studies is needed to elaborate on the mechanism. Cancer Epidemiol Biomarkers Prev; 20(5); 990–1002. ©2011 AACR.This publication has 52 references indexed in Scilit:
- Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyThe Lancet, 2011
- Age-Specific Prevalence of and Risk Factors for Anal Human Papillomavirus (HPV) among Men Who Have Sex with Women and Men Who Have Sex with Men: The HPV in Men (HIM) StudyThe Journal of Infectious Diseases, 2011
- Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the LiteratureSexually Transmitted Diseases, 2010
- Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in Men Who Have Sex with Women: A Cross‐National StudyThe Journal of Infectious Diseases, 2010
- Male Circumcision Decreases Acquisition and Increases Clearance of High‐Risk Human Papillomavirus in HIV‐Negative Men: A Randomized Trial in Rakai, UgandaThe Journal of Infectious Diseases, 2010
- Reduced Clearance of Penile Human Papillomavirus Infection in Uncircumcised MenThe Journal of Infectious Diseases, 2010
- Test-Retest Reliability of a Sexual Behavior Interview for Men Residing in Brazil, Mexico, and the United States: The HPV in Men (HIM) StudyAmerican Journal of Epidemiology, 2009
- Effect of Male Circumcision on the Prevalence of High-Risk Human Papillomavirus in Young Men: Results of a Randomized Controlled Trial Conducted in Orange Farm, South AfricaThe Journal of Infectious Diseases, 2009
- Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003Cancer, 2008
- Circumcision and sexual behavior: Factors independently associated with human papillomavirus detection among men in the HIM studyInternational Journal of Cancer, 2008